Starling Oncology, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $203.0M | $-45.9M | $-10.9M |
| FY2022 | $252.5M | $-82.0M | $152.0K |
| FY2023 | $324.2M | $-77.0M | $-83.1M |
| FY2024 | $393.4M | $-60.1M | $-64.7M |
| FY2025 | $502.7M | $-36.1M | $-60.6M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $203.0M | $-45.9M | $-10.9M |
| FY2022 | $252.5M | $-82.0M | $152.0K |
| FY2023 | $324.2M | $-77.0M | $-83.1M |
| FY2024 | $393.4M | $-60.1M | $-64.7M |
| FY2025 | $502.7M | $-36.1M | $-60.6M |